Incentives Available for Early Use of E-Prescribing

Evaluation activity should basically clear and provide context for the improvement ofmanagement processes for the better future . This should be realized by every management withinthe company wherever located . Clarity measurement tools will help achieve the objectives of thecompany later . One of the measuring instruments are applied is BSC (Balance Score Card ).BSC Assist management to evaluate and help correct the exact performance of the company.At first , the BSC is used to improve executive performance measurement system. Early use of theexecutive's performance is measured only in terms of finances. Then developed into a morespacious with four perspectives, which are then used to measure the performance of theorganization as a whole . The four perspectives, namely financial, customer, internal businessprocesses and learning and growth .In the development of the BSC has helped many companies to successfully achieve its goals. BSChas several advantages that are not owned traditional systems management strategy. Theadvantages of the BSC approach in the strategic planning system is able to produce a strategicplan, which has the characteristics : a comprehensive, coherent, balanced and measured .Basin , is an area that needs attention . Governments and communities must work together toachieve clean rivers, healthy, and productive and provide sustainable benefits to the surroundingcommunity. If the indicators are assessed in the score card is identical to the indicators used inthe monitoring and evaluation of the basin, the score card is also a tool for monitoring andevaluation of the river basin

Download Full-text

Faculty Opinions recommendation of Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1163099.623758 ◽

2009 ◽

Author(s):

Martin Duenser

Keyword(s):

Septic Shock ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Polymyxin B ◽

Randomized Controlled ◽

Early Use ◽

Polymyxin B Hemoperfusion

Download Full-text

Faculty Opinions recommendation of Early use of TIPS in patients with cirrhosis and variceal bleeding.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4436956.793499799 ◽

2014 ◽

Author(s):

Tilman Sauerbruch

Keyword(s):

Variceal Bleeding ◽

Early Use

Download Full-text

The Ugly Side of Colchicine

Journal of Investigative Medicine High Impact Case Reports ◽

10.1177/23247096211029744 ◽

2021 ◽

Vol 9 ◽

pp. 232470962110297

Author(s):

Justin Cozza ◽

Tuong Vi Cassandra Do ◽

Shyam Ganti ◽

Jayaramakrishna Depa

Keyword(s):

Liver Failure ◽

Acute Liver Failure ◽

Activated Charcoal ◽

The United States ◽

Multiple Organ ◽

Poison Control ◽

Fab Fragments ◽

Early Use ◽

Potential Use ◽

Electrolyte Abnormalities

We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute liver failure, rhabdomyolysis, and lactic acidosis. He also developed electrolyte abnormalities and refractory hypoglycemia. Initial treatment consisted of activated charcoal, fluids, and broad-spectrum antibiotics with supportive treatment of mechanical ventilation, hemodialysis, vasopressors, N-acetylcysteine, colony-stimulating factors, and blood products. Literature shows potential benefit of colchicine-specific Fab fragments for acute toxicity with limited studies and is not currently available in the United States. Further research for N-acetylcysteine protocol for acute liver failure in colchicine toxicity and potential use of colchicine-specific Fab fragments is needed. Our case demonstrates the importance of early use of activated charcoal for ingestion overdose with the incorporation of poison control into multidisciplinary team for coordinated patient care.

Download Full-text

New Potential Biomarkers for Chronic Kidney Disease Management—A Review of the Literature

International Journal of Molecular Sciences ◽

10.3390/ijms22010043 ◽

2020 ◽

Vol 22 (1) ◽

pp. 43

Author(s):

Irina Lousa ◽

Flávio Reis ◽

Idalina Beirão ◽

Rui Alves ◽

Luís Belo ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Clinical Practice ◽

Kidney Disease ◽

Renal Damage ◽

Recent Literature ◽

Therapeutic Interventions ◽

Review Of The Literature ◽

Medical Need ◽

Early Use ◽

Reasonable Approach

The prevalence of chronic kidney disease (CKD) is increasing worldwide, and the mortality rate continues to be unacceptably high. The biomarkers currently used in clinical practice are considered relevant when there is already significant renal impairment compromising the early use of potentially successful therapeutic interventions. More sensitive and specific biomarkers to detect CKD earlier on and improve patients’ prognoses are an important unmet medical need. The aim of this review is to summarize the recent literature on new promising early CKD biomarkers of renal function, tubular lesions, endothelial dysfunction and inflammation, and on the auspicious findings from metabolomic studies in this field. Most of the studied biomarkers require further validation in large studies and in a broad range of populations in order to be implemented into routine CKD management. A panel of biomarkers, including earlier biomarkers of renal damage, seems to be a reasonable approach to be applied in clinical practice to allow earlier diagnosis and better disease characterization based on the underlying etiologic process.

Download Full-text